NDC 65219-586-04
TYENNE 162 mg/.9mL
Tocilizumab-aazg · INJECTION, SOLUTION
TYENNE is a injection, solution containing tocilizumab-aazg at a strength of 162 mg/.9mL. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- TYENNE
- Generic Name
- Tocilizumab-aazg
- NDC Code (Package)
65219-586-04- NDC Code (Product)
65219-586- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 162 mg/.9mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761275
- Drug Class
- Interleukin-6 Receptor Antagonist [EPC]
- Marketing Start
- 07/01/2024
Recall History
No Recall HistoryView Full Drug Page
TYENNE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.